+ Watch ATRS
on My Watchlist
The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.
Along with gel transdermal delivery systems for drugs, they have pioneered and exploited the use of disposable pens which deliver Epinephrine for allegic reactions as well as adjustable dosage pens for insulin delivery and methotrexate for arthritis pain. Recently approved by FDA for Metho-pens. Owned since it was .89 per share.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions